Cambridge University Press, Journal of Law, Medicine and Ethics, 4(37), p. 685-687, 2009
DOI: 10.1111/j.1748-720x.2009.00440.x
Full text: Download
This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science.